Advisor Group Holdings, Inc. Regenxbio Inc. Transaction History

Advisor Group Holdings, Inc.

$42.2 Billion
Q3 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Regenxbio Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 480 shares of RGNX stock, worth $3,657. This represents 0.0% of its overall portfolio holdings.

Number of Shares

480

Previous 457 5.03%

Holding current value

$3,657

Previous $5,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$10.49 - $14.39 $241 - $330	23 Added 5.03%	480 $5,000
Q2 2024 Aug 13, 2024	SELL	$11.51 - $21.53 $4,235 - $7,923	-368 Reduced 44.61%	457 $5,000
Q1 2024 May 10, 2024	SELL	$12.17 - $24.61 $8,811 - $17,817	-724 Reduced 46.74%	825 $17,000
Q4 2023 Feb 12, 2024	SELL	$12.89 - $20.82 $15,661 - $25,296	-1,215 Reduced 43.96%	1,549 $27,000
Q3 2023 Nov 13, 2023	BUY	$16.46 - $19.99 $971 - $1,179	59 Added 2.18%	2,764 $45,000
Q2 2023 Aug 10, 2023	SELL	$17.23 - $21.71 $3,652 - $4,602	-212 Reduced 7.27%	2,705 $54,000
Q1 2023 May 12, 2023	SELL	$18.08 - $24.55 $61,598 - $83,641	-3,407 Reduced 53.87%	2,917 $55,000
Q4 2022 Feb 10, 2023	BUY	$20.4 - $24.73 $40 - $49	2 Added 0.03%	6,324 $143,000
Q3 2022 Nov 14, 2022	BUY	$22.29 - $35.04 $7,221 - $11,352	324 Added 5.4%	6,322 $167,000
Q2 2022 Aug 10, 2022	SELL	$19.35 - $35.04 $9,539 - $17,274	-493 Reduced 7.6%	5,998 $147,000
Q1 2022 May 04, 2022	BUY	$24.62 - $34.31 $28,633 - $39,902	1,163 Added 21.83%	6,491 $215,000
Q3 2021 Nov 05, 2021	SELL	$29.09 - $45.68 $323,364 - $507,778	-11,116 Reduced 67.6%	5,328 $223,000
Q2 2021 Aug 02, 2021	BUY	$32.46 - $40.48 $39,503 - $49,264	1,217 Added 7.99%	16,444 $639,000
Q1 2021 May 13, 2021	BUY	$33.61 - $49.95 $297,414 - $442,007	8,849 Added 138.74%	15,227 $519,000
Q4 2020 Feb 10, 2021	BUY	$26.52 - $49.35 $126,394 - $235,202	4,766 Added 295.66%	6,378 $290,000
Q3 2020 Nov 12, 2020	BUY	$27.01 - $40.26 $7,913 - $11,796	293 Added 22.21%	1,612 $45,000
Q2 2020 Aug 14, 2020	SELL	$27.75 - $43.44 $3,940 - $6,168	-142 Reduced 9.72%	1,319 $49,000
Q1 2020 May 18, 2020	BUY	$21.5 - $54.2 $31,411 - $79,186	1,461 New	1,461 $48,000

Others Institutions Holding RGNX

# of Institutions

196

Shares Held

43M

Call Options Held

104K

Put Options Held

478K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $329M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Regenxbio Inc. Transaction History